367 related articles for article (PubMed ID: 29074533)
1. Novel Antithrombotic Drugs on the Horizon: The Ultimate Promise to Prevent Clotting While Avoiding Bleeding.
McFadyen JD; Peter K
Circ Res; 2017 Oct; 121(10):1133-1135. PubMed ID: 29074533
[No Abstract] [Full Text] [Related]
2. Antithrombotic agents and invasive procedures--hematologist point of view.
Lecompte TP
Thromb Res; 2012 Oct; 130 Suppl 1():S61-2. PubMed ID: 23026666
[TBL] [Abstract][Full Text] [Related]
3. Future Antithrombotic Therapies in Cardiology.
Bäuml M; Hilgendorf I
Hamostaseologie; 2018 Nov; 38(4):236-239. PubMed ID: 30267387
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic therapy in medically managed patients with non-ST-segment elevation acute coronary syndromes.
Gurbel PA; Tantry US
Heart; 2016 Jun; 102(11):882-92. PubMed ID: 26944654
[No Abstract] [Full Text] [Related]
5. [Reduction of haemorrhagic risk in acute coronary syndromes].
Merino A; Roldán I; Marín F; Worner F;
Med Clin (Barc); 2011 Nov; 137(14):650-5. PubMed ID: 20701931
[No Abstract] [Full Text] [Related]
6. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
Rubboli A; Halperin JL
Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
[No Abstract] [Full Text] [Related]
7. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
Roldán V; Marín F
Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
[No Abstract] [Full Text] [Related]
8. Bleeding risks of antithrombotic therapy.
Fitzmaurice DA; Blann AD; Lip GY
BMJ; 2002 Oct; 325(7368):828-31. PubMed ID: 12376447
[No Abstract] [Full Text] [Related]
9. Antithrombotic therapies in children on durable Ventricular Assist Devices: A literature review.
Huang JY; Monagle P; Massicotte MP; VanderPluym CJ
Thromb Res; 2018 Dec; 172():194-203. PubMed ID: 29501323
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategies for thrombosis: new targets and approaches.
Mackman N; Bergmeier W; Stouffer GA; Weitz JI
Nat Rev Drug Discov; 2020 May; 19(5):333-352. PubMed ID: 32132678
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic therapy: new areas to understand efficacy and bleeding.
Wisler JW; Becker RC
Expert Opin Ther Targets; 2014 Dec; 18(12):1427-34. PubMed ID: 25347453
[TBL] [Abstract][Full Text] [Related]
12. [Managing antithrombotic therapy in vitreoretinal surgery].
Gallice M; Rouberol F; Albaladejo P; Brillat Zaratzian E; Palombi K; Aptel F; Romanet JP; Chiquet C
J Fr Ophtalmol; 2015 Jan; 38(1):61-73. PubMed ID: 25577431
[TBL] [Abstract][Full Text] [Related]
13. Impact of race and gender on antithrombotic therapy.
Capodanno D; Angiolillo DJ
Thromb Haemost; 2010 Sep; 104(3):471-84. PubMed ID: 20664898
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic treatment in peripheral artery disease.
Olinic DM; Tataru DA; Homorodean C; Spinu M; Olinic M
Vasa; 2018 Feb; 47(2):99-108. PubMed ID: 29160765
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic therapy for the CardioWest temporary total artificial heart.
Ensor CR; Cahoon WD; Crouch MA; Katlaps GJ; Hess ML; Cooke RH; Gunnerson KJ; Kasirajan V
Tex Heart Inst J; 2010; 37(2):149-58. PubMed ID: 20401285
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic therapy in peripheral artery disease.
Foley TR; Waldo SW; Armstrong EJ
Vasc Med; 2016 Apr; 21(2):156-69. PubMed ID: 26823456
[TBL] [Abstract][Full Text] [Related]
17. Contemporary Use of Oral Antithrombotic Agents: Focus on Dual and Triple Therapeutic Approaches.
Jenkins AT; Kantorovich A; Burman L
Pharmacotherapy; 2017 Dec; 37(12):1545-1564. PubMed ID: 28981961
[TBL] [Abstract][Full Text] [Related]
18. [Thrombosis and cancer. An update of our knowledge].
Tumori; 2006; 92(5):23-41. PubMed ID: 17168451
[No Abstract] [Full Text] [Related]
19. The search for new antithrombotic mechanisms and therapies that may spare hemostasis.
Plow EF; Wang Y; Simon DI
Blood; 2018 Apr; 131(17):1899-1902. PubMed ID: 29467183
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic therapy for acute coronary syndrome: Past, present and future.
Sibbing D; Angiolillo DJ; Huber K
Thromb Haemost; 2017 Jun; 117(7):1240-1248. PubMed ID: 28594051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
